NovaBay Pharmaceuticals, Inc. P/B ratio

P/B ratio of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including P/B ratio growth rates and interactive chart. Measures the relationship between price and book value per share. Book value is the equity or owner's capital that is invested in a business. If a stock has a price of $10 and a book value per share of $10, the ratio is 1. Stock selling below a P/B of 1 can be a bargain, as the market price has declined below the net asset value of the business. It is more applicable to financial companies like banks and insurers, as their assets and liabilities are valued at market and the book value thus more accuraterly represents reality.


Highlights and Quick Summary

Current P/B ratio of NovaBay Pharmaceuticals, Inc. is 1.81 (as of December 31, 2021)
  • P/B ratio for the quarter ending June 30, 2022 was 0.87 (a -0.91% decrease compared to previous quarter)
  • Year-over-year quarterly P/B ratio decreased by -71.7%
  • Annual P/B ratio for 2021 was 1.81 (a -8.99% decrease from previous year)
  • Annual P/B ratio for 2020 was 1.99 (a -86.0% decrease from previous year)
  • Annual P/B ratio for 2019 was 14.23 (a 441.24% increase from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical P/B ratio of NovaBay Pharmaceuticals, Inc.

Most recent P/B ratioof NBY including historical data for past 10 years.

Interactive Chart of P/B ratio of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. P/B ratio for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.87 0.88
2021 1.81 3.07 2.54 3.46 1.81
2020 1.99 2.11 35.55 0.0 1.99
2019 14.23 4.82 19.29 17.41 14.23
2018 2.63 4.82 5.75 6.47 2.63
2017 24.22 37.89 18.37 13.4 24.22
2016 4.29 6.66 0.0 0.0 4.29
2015 0.0 94.44 8.39 17.46 0.0
2014 16.92 7.5 4.35 4.48 16.92
2013 5.51 11.89 6.72 5.44 5.51
2012 2.37 5.08 6.03 5.04 2.37
2011 3.67 1.88 3.67

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology